Charles River, Akadeum Life Sciences announce collaboration

Charles River (CRL) and Akadeum Life Sciences announced the integration of Akadeum’s GMP-grade Human T Cell Leukopak Isolation Kit into Charles River’s Cell Therapy Flex Program. Charles River’s Cell Therapy Flex Platform originated as an off-the-shelf solution for Cell Therapy Process Development, providing ready-to-use platforms and protocols validated for autologous CAR-T and TCR-T cell therapies to minimize risk, lower costs, and accelerate development timelines. Automated platforms with closed systems include protocols from cell selection and expansion to electroporation and viral vector methods, wash/concentration, and fill and finish.